Q3 2025 Earnings Call Transcript November 12, 2025 Humacyte, Inc. beats earnings expectations. Reported EPS is $-0.14, ...

Total revenues of $753,000 for third quarter, and $1,571,000 for first nine months of 2025, from sales and collaborative research agreement - - Major advances in pipeline as Humacyte moves closer to ...

Humacyte, Inc. ( HUMA) Q3 2025 Earnings Call November 12, 2025 8:00 AM EST Good morning, ladies and gentlemen, and welcome to the Humacyte's Third Quarter Results Conference Call. [Operator ...

Humacyte's Q3 2025 earnings show strong Symvess sales growth, expanded hospital/military access, and financial stability.

Fintel reports that on October 21, 2025, Citigroup upgraded their outlook for Claritev (NYSE:CTEV) from Neutral to Buy. Analyst Price Forecast Suggests 22.59% Upside As of September 30, 2025, the ...

On October 8, 2025, iO Health-FZE announced an exclusive strategic alliance with Claritev Corporation to deliver the Optima AI healthcare platform across the Middle East and North Africa, granting ...

Weight-loss surgery dramatically outperformed GLP-1 medications in improving longevity and reducing heart, kidney, and eye complications for people with obesity and diabetes. Over 10 years, patients ...

Bon Jovi is going back on the road. The rock band announced the upcoming Forever Tour on Wednesday, marking their first tour since frontman Jon Bon Jovi underwent vocal cord surgery in 2022. The ...

Penn State quarterback Drew Allar underwent successful surgery Wednesday on his broken left ankle, sources told ESPN's Pete Thamel. Allar is on track for a full recovery, as his timeline to return to ...

The Pittsburgh Steelers received an unfortunate injury update on the heart and soul of their special teams unit, as team captain S Miles Killebrew underwent season-ending knee surgery ahead of the ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...